methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate

Modify Date: 2025-10-03 16:00:59

methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate Structure
methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate structure
 Common Name methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate
CAS Number 4151-06-8 Molecular Weight 200.27800
Density N/A Boiling Point N/A
Molecular Formula C10H20N2O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate

 Chemical & Physical Properties

Molecular Formula C10H20N2O2
Molecular Weight 200.27800
Exact Mass 200.15200
PSA 32.78000
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
N-[(4-fluoropiperidin-4-yl)methyl]-2,2-dimethylpropanamide hydrochloride
2877751-71-6
1-(4-Methanesulfonylphenyl)pyrrolidine-2-carboxamide
2877628-87-8
3-Fluoro-1-{imidazo[1,2-a]pyrazin-8-yl}pyrrolidine
2877767-13-8
1-{2-Ethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl}methanamine dihydrochloride
2877705-15-0
6-[4-(6-Cyclopropylpyrimidin-4-yl)-1,4-diazepan-1-yl]pyridazine-3-carbonitrile
2877761-06-1
[(Azepan-4-yl)methyl]dimethylamine dihydrochloride
2832911-76-7
6-[4-(6-Methylpyrimidin-4-yl)-1,4-diazepan-1-yl]pyridazine-3-carbonitrile
2877718-32-4
N-cyclopropyl-2-(trifluoromethyl)imidazo[1,2-a]pyrazin-8-amine
2877703-17-6
1-[(4-fluorophenyl)methyl]-N-(oxan-4-yl)piperidine-3-carboxamide
2877751-76-1
6-[4-(5-Fluoropyrimidin-2-yl)-1,4-diazepan-1-yl]pyridazine-3-carbonitrile
2877663-89-1
Chemsrc provides CAS#:4151-06-8 MSDS, density, melting point, boiling point, structure, etc. Its name is methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate>> amp version: methyl 2-methyl-3-(4-methylpiperazin-1-yl)propanoate

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved